A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Exendin-4 Fc fusion protein injection(1.2mg)OngoingActive not recruitingPhase 3Open NCT06257966 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT06257966 · Trial Tracker · ComplyRx